DAA291 |
chromosome 1 open reading frame 162 |
Molecular |
kidney |
Human |
C1orf162 |
37.0% Increase Gene Expression Level |
|
DAA290 |
lysozyme (renal amyloidosis) |
Molecular |
kidney |
Human |
LYZ |
57.0% Increase Gene Expression Level |
|
DAA289 |
brain protein 44-like |
Molecular |
kidney |
Human |
BRP44L |
9.0% Decrease Gene Expression Level |
|
DAA288 |
complement component 1, r subcomponent |
Molecular |
kidney |
Human |
C1R |
21.0% Increase Gene Expression Level |
|
DAA287 |
creatine kinase, brain |
Molecular |
kidney |
Human |
CKB |
10.0% Decrease Gene Expression Level |
|
DAA286 |
StAR-related lipid transfer (START) domain containing 8 |
Molecular |
kidney |
Human |
STARD8 |
14.0% Decrease Gene Expression Level |
|
DAA285 |
immunoglobulin kappa variable 1-5 |
Molecular |
kidney |
Human |
IGKV1-5 |
35.0% Increase Gene Expression Level |
|
DAA284 |
immunoglobulin lambda variable 4-3 |
Molecular |
kidney |
Human |
IGLV4-3 |
41.0% Increase Gene Expression Level |
|
DAA283 |
lactotransferrin |
Molecular |
kidney |
Human |
LTF |
115.0% Increase Gene Expression Level |
|
DAA282 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
Molecular |
kidney |
Human |
SERPINA5 |
11.0% Decrease Gene Expression Level |
|
DAA281 |
coiled-coil domain containing 3 |
Molecular |
kidney |
Human |
CCDC3 |
19.0% Increase Gene Expression Level |
|
DAA280 |
FXYD domain containing ion transport regulator 2 |
Molecular |
kidney |
Human |
FXYD2 |
5.0% Decrease Gene Expression Level |
|
DAA279 |
nicotinamide N-methyltransferase |
Molecular |
kidney |
Human |
NNMT |
40.0% Increase Gene Expression Level |
|
DAA278 |
Ras-related GTP binding D |
Molecular |
kidney |
Human |
RRAGD |
14.0% Decrease Gene Expression Level |
|
DAA277 |
tyrosinase-related protein 1 |
Molecular |
kidney |
Human |
TYRP1 |
21.0% Decrease Gene Expression Level |
|
DAA276 |
Rh family, C glycoprotein |
Molecular |
kidney |
Human |
RHCG |
16.0% Decrease Gene Expression Level |
|
DAA275 |
complement component 1, q subcomponent, C chain |
Molecular |
kidney |
Human |
C1QC |
27.0% Increase Gene Expression Level |
|
DAA274 |
immunoglobulin lambda variable 3-25 |
Molecular |
kidney |
Human |
IGLV3-25 |
46.0% Increase Gene Expression Level |
|
DAA273 |
cytoplasmic FMR1 interacting protein 2 |
Molecular |
kidney |
Human |
CYFIP2 |
11.0% Decrease Gene Expression Level |
|
DAA272 |
dedicator of cytokinesis 11 |
Molecular |
kidney |
Human |
DOCK11 |
24.0% Increase Gene Expression Level |
|
DAA271 |
epidermal growth factor (beta-urogastrone) |
Molecular |
kidney |
Human |
EGF |
25.0% Decrease Gene Expression Level |
|
DAA270 |
lipoprotein lipase |
Molecular |
kidney |
Human |
LPL |
17.0% Decrease Gene Expression Level |
|
DAA269 |
alpha-kinase 2 |
Molecular |
kidney |
Human |
ALPK2 |
20.0% Increase Gene Expression Level |
|
DAA268 |
solute carrier family 12 (sodium/chloride transporters), member 3 |
Molecular |
kidney |
Human |
SLC12A3 |
16.0% Decrease Gene Expression Level |
|
DAA267 |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
Molecular |
kidney |
Human |
APBB1IP |
23.0% Increase Gene Expression Level |
|